找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phospho; W. R. Bartle,V. Braun,N. E. Winslade

[復制鏈接]
樓主: NO610
11#
發(fā)表于 2025-3-23 10:03:40 | 只看該作者
Biopharmacological Regulation of Protein Phosphorylation,we indicate the inhibition or activation mechanisms of each compound and examine selectivity for each kinase, then describe the representative experiments of biological applications of these compounds. The possible clinical application of these compounds warrant attention.
12#
發(fā)表于 2025-3-23 16:30:00 | 只看該作者
0177-8757 addition, certain specialized tissues use cholesterol as the basic substrate for the synthesis of more complicated sterols such as bile acids and the steroid hormones. Like most lipids cholesterol has a very low solubility in water. Therefore, in order for these molecules to be transported be- twee
13#
發(fā)表于 2025-3-23 18:36:21 | 只看該作者
14#
發(fā)表于 2025-3-24 00:34:37 | 只看該作者
Pharmacokinetic Drug Interactions,s review discusses the various pharmacokinetic mechanisms involved in these changes and discusses several drug and patient-specific factors that aid in assessing the clinical significance of these interactions.
15#
發(fā)表于 2025-3-24 02:52:56 | 只看該作者
Regulation of Plasma Low Density Lipoprotein Levels: New Strategies for Drug Design,or-dependent LDL-cholesterol degradation accounts for the majority of total LDL-cholesterol degradation in all species studied. Third, in quantitative terms, receptor-dependent LDL-cholesterol degradation is restricted to the liver and, to a lesser extent, the small intestine. It is also clear that
16#
發(fā)表于 2025-3-24 06:47:58 | 只看該作者
17#
發(fā)表于 2025-3-24 13:07:51 | 只看該作者
Conference proceedings 1988seen. Since it has been demonstrated that reducing the steady-state plasma LDL-cholesterol concentration produces a proportional decrease in the risk of developing atherosclerosis 2), a major effort is now underway to develop safe and effective lipid lowering agents. In the past, these efforts have
18#
發(fā)表于 2025-3-24 16:35:29 | 只看該作者
0177-8757 the risk of developing atherosclerosis 2), a major effort is now underway to develop safe and effective lipid lowering agents. In the past, these efforts have 978-3-642-72904-1978-3-642-72902-7Series ISSN 0177-8757
19#
發(fā)表于 2025-3-24 22:27:22 | 只看該作者
20#
發(fā)表于 2025-3-25 01:01:03 | 只看該作者
s of this social reality. Finally, the authors examine new challenges emerging from recent paradigm shifts within forensic genetics, moving away from the construction of evidence as presented in court to the production of intelligence guiding criminal investigations.978-981-15-2429-5
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 09:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
孟津县| 新蔡县| 石景山区| 鄄城县| 乌兰察布市| 芦山县| 石狮市| 合肥市| 韶关市| 镇赉县| 潼关县| 柘城县| 凯里市| 绍兴县| 习水县| 临泉县| 明光市| 禄劝| 新丰县| 诸暨市| 宜都市| 长治县| 枝江市| 黄冈市| 青河县| 闵行区| 芜湖县| 襄汾县| 温州市| 蒲城县| 秦皇岛市| 诏安县| 乐山市| 阿城市| 讷河市| 丽水市| 许昌县| 富宁县| 乌鲁木齐市| 宁化县| 怀宁县|